Search

everythinglearnresearchcommunity

for

Search:↓

The treatment was ineffective in humans.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Current treatments for alopecia show no significant long-term benefits.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Chitosan nanoparticles improve minoxidil delivery to hair follicles for better alopecia treatment.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Some birth control pills have a higher risk of blood clots than others.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Hydrogels could lead to better treatments for wound healing without scars.

The new method improves bone repair by enhancing cell loading and stability in bioprinted scaffolds.

Laser treatment increases hair density and thickness safely in women with hair loss.

Chitosan microparticles improve minoxidil sulphate delivery, potentially reducing daily applications.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Using microneedles before applying eflornithine cream can make it more effective at stopping hair growth.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.